-
1
-
-
84895832615
-
Global estimates of diabetes prevalence for 2013 and projections for 2035
-
Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2): 137-49.
-
(2014)
Diabetes Res Clin Pract
, vol.103
, Issue.2
, pp. 137-149
-
-
Guariguata, L.1
Whiting, D.R.2
Hambleton, I.3
-
2
-
-
79952932916
-
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes
-
Jimenez-Solem E, Rasmussen MH, Christensen M, Knop FK. Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes. Curr Opin Mol Ther. 2010; 12(6): 790-7.
-
(2010)
Curr Opin Mol Ther
, vol.12
, Issue.6
, pp. 790-797
-
-
Jimenez-Solem, E.1
Rasmussen, M.H.2
Christensen, M.3
Knop, F.K.4
-
3
-
-
84891859045
-
Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors
-
Offermanns S. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annu Rev Pharmacol Toxicol. 2014; 54: 407-34.
-
(2014)
Annu Rev Pharmacol Toxicol
, vol.54
, pp. 407-434
-
-
Offermanns, S.1
-
5
-
-
0038363378
-
The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids
-
Brown AJ, Goldsworthy SM, Barnes AA, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003, 278(13), 11312-9.
-
(2003)
J Biol Chem
, vol.278
, Issue.13
, pp. 11312-11319
-
-
Brown, A.J.1
Goldsworthy, S.M.2
Barnes, A.A.3
-
6
-
-
0037838892
-
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
-
Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003; 278(13): 11303-11.
-
(2003)
J Biol Chem
, vol.278
, Issue.13
, pp. 11303-11311
-
-
Briscoe, C.P.1
Tadayyon, M.2
Rews, J.L.3
-
7
-
-
0037434991
-
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40
-
Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003; 422(6928): 173-6.
-
(2003)
Nature
, vol.422
, Issue.6928
, pp. 173-176
-
-
Itoh, Y.1
Kawamata, Y.2
Harada, M.3
-
8
-
-
0037423719
-
A human cell surface receptor activated by free fatty acids and thiazolidin- edione drugs
-
Kotarsky K, Nilsson NE, Flodgren E, Owman C, Olde B. A human cell surface receptor activated by free fatty acids and thiazolidin- edione drugs. Biochemical and Biophysical Research Communica- tions. 2003; 301(2): 406-10.
-
(2003)
Biochemical and Biophysical Research Communica- Tions
, vol.301
, Issue.2
, pp. 406-410
-
-
Kotarsky, K.1
Nilsson, N.E.2
Flodgren, E.3
Owman, C.4
Olde, B.5
-
9
-
-
0038491435
-
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation
-
Le Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003; 278(28): 25481-9.
-
(2003)
J Biol Chem
, vol.278
, Issue.28
, pp. 25481-25489
-
-
Le Poul, E.1
Loison, C.2
Struyf, S.3
-
10
-
-
0037453280
-
Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids
-
Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003; 303(4): 1047-52.
-
(2003)
Biochem Biophys Res Commun
, vol.303
, Issue.4
, pp. 1047-1052
-
-
Nilsson, N.E.1
Kotarsky, K.2
Owman, C.3
Olde, B.4
-
11
-
-
77956165390
-
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin- sensitizing effects
-
Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin- sensitizing effects. Cell. 2010; 142(5): 687-98.
-
(2010)
Cell
, vol.142
, Issue.5
, pp. 687-698
-
-
Oh, D.Y.1
Talukdar, S.2
Bae, E.J.3
-
12
-
-
79956348319
-
Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)
-
Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011; 108(19): 8030-5.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.19
, pp. 8030-8035
-
-
Kimura, I.1
Inoue, D.2
Maeda, T.3
-
13
-
-
84858285593
-
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human
-
Ichimura A, Hirasawa A, Poulain-Godefroy O, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012; 483(7389): 350-4.
-
(2012)
Nature
, vol.483
, Issue.7389
, pp. 350-354
-
-
Ichimura, A.1
Hirasawa, A.2
Poulain-Godefroy, O.3
-
14
-
-
84860476011
-
Omega 3 fatty acids and GPR120
-
Oh DY, Olefsky JM. Omega 3 fatty acids and GPR120. Cell Metab. 2012; 15(5): 564-5.
-
(2012)
Cell Metab
, vol.15
, Issue.5
, pp. 564-565
-
-
Oh, D.Y.1
Olefsky, J.M.2
-
15
-
-
84878579044
-
The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43
-
Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013; 4: 1829.
-
(2013)
Nat Commun
, vol.4
, pp. 1829
-
-
Kimura, I.1
Ozawa, K.2
Inoue, D.3
-
16
-
-
0025321505
-
Energy contributions of volatile fatty acids from the gastrointestinal tract in various species
-
Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990; 70(2): 567-90.
-
(1990)
Physiol Rev
, vol.70
, Issue.2
, pp. 567-590
-
-
Bergman, E.N.1
-
17
-
-
38349049462
-
Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis
-
Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 2008; 6(2): 121-31.
-
(2008)
Nat Rev Microbiol
, vol.6
, Issue.2
, pp. 121-131
-
-
Flint, H.J.1
Bayer, E.A.2
Rincon, M.T.3
Lamed, R.4
White, B.A.5
-
18
-
-
0031581088
-
A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1
-
Sawzdargo M, George SR, Nguyen T, et al. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem Biophys Res Commun. 1997; 239(2): 543-7.
-
(1997)
Biochem Biophys Res Commun
, vol.239
, Issue.2
, pp. 543-547
-
-
Sawzdargo, M.1
George, S.R.2
Nguyen, T.3
-
19
-
-
55949091259
-
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
-
Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008; 105(43): 16767-72.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.43
, pp. 16767-16772
-
-
Samuel, B.S.1
Shaito, A.2
Motoike, T.3
-
20
-
-
84856509724
-
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein- coupled receptor FFAR2
-
Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein- coupled receptor FFAR2. Diabetes. 2012; 61(2): 364-71.
-
(2012)
Diabetes
, vol.61
, Issue.2
, pp. 364-371
-
-
Tolhurst, G.1
Heffron, H.2
Lam, Y.S.3
-
21
-
-
27844440904
-
Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43
-
Hong YH, Nishimura Y, Hishikawa D, et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005; 146(12): 5092-9.
-
(2005)
Endocrinology
, vol.146
, Issue.12
, pp. 5092-5099
-
-
Hong, Y.H.1
Nishimura, Y.2
Hishikawa, D.3
-
22
-
-
54549087794
-
Anatomical profiling of G protein-coupled receptor expression
-
Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell. 2008; 135(3): 561-71.
-
(2008)
Cell
, vol.135
, Issue.3
, pp. 561-571
-
-
Regard, J.B.1
Sato, I.T.2
Coughlin, S.R.3
-
23
-
-
70350666634
-
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
-
Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268): 1282-6.
-
(2009)
Nature
, vol.461
, Issue.7268
, pp. 1282-1286
-
-
Maslowski, K.M.1
Vieira, A.T.2
Ng, A.3
-
24
-
-
0037239166
-
Role of dietary fiber and short-chain fatty acids in the colon
-
Andoh A, Tsujikawa T, Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr Pharm Des. 2003; 9(4): 347-58.
-
(2003)
Curr Pharm Des
, vol.9
, Issue.4
, pp. 347-358
-
-
Oh, A.1
Tsujikawa, T.2
Fujiyama, Y.3
-
25
-
-
13344282056
-
A role for glucagon-like peptide-1 in the central regulation of feeding
-
Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996; 379(6560): 69-72.
-
(1996)
Nature
, vol.379
, Issue.6560
, pp. 69-72
-
-
Turton, M.D.1
O'shea, D.2
Gunn, I.3
-
26
-
-
0037043704
-
Gut hormone PYY(336) physiologically inhibits food intake
-
Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(336) physiologically inhibits food intake. Nature. 2002; 418(6898): 650-4.
-
(2002)
Nature
, vol.418
, Issue.6898
, pp. 650-654
-
-
Batterham, R.L.1
Cowley, M.A.2
Small, C.J.3
-
27
-
-
12344332415
-
Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats
-
Chelikani PK, Haver AC, Reidelberger RD. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology. 2005; 146(2): 879-88.
-
(2005)
Endocrinology
, vol.146
, Issue.2
, pp. 879-888
-
-
Chelikani, P.K.1
Haver, A.C.2
Reidelberger, R.D.3
-
28
-
-
33646376658
-
Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine
-
Karaki S, Mitsui R, Hayashi H, et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 2006; 324(3): 353-60.
-
(2006)
Cell Tissue Res
, vol.324
, Issue.3
, pp. 353-360
-
-
Karaki, S.1
Mitsui, R.2
Hayashi, H.3
-
29
-
-
28744450411
-
Peptide YY is secreted after oral glucose administration in a gender-specific manner
-
Kim BJ, Carlson OD, Jang HJ, et al. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab. 2005; 90(12): 6665-71.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.12
, pp. 6665-6671
-
-
Kim, B.J.1
Carlson, O.D.2
Jang, H.J.3
-
30
-
-
50449087891
-
Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids
-
Ge H, Li X, Weiszmann J, et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology. 2008; 149(9): 4519-26.
-
(2008)
Endocrinology
, vol.149
, Issue.9
, pp. 4519-4526
-
-
Ge, H.1
Li, X.2
Weiszmann, J.3
-
31
-
-
74049124329
-
Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines
-
Cox MA, Jackson J, Stanton M, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol. 2009; 15(44): 5549-57.
-
(2009)
World J Gastroenterol
, vol.15
, Issue.44
, pp. 5549-5557
-
-
Cox, M.A.1
Jackson, J.2
Stanton, M.3
-
32
-
-
84893794477
-
G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells
-
Masui R, Sasaki M, Funaki Y, et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis. 2013; 19(13): 2848-56.
-
(2013)
Inflamm Bowel Dis
, vol.19
, Issue.13
, pp. 2848-2856
-
-
Masui, R.1
Sasaki, M.2
Funaki, Y.3
-
33
-
-
73349123182
-
G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation
-
Sina C, Gavrilova O, Forster M, et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009; 183(11): 7514-22.
-
(2009)
J Immunol
, vol.183
, Issue.11
, pp. 7514-7522
-
-
Sina, C.1
Gavrilova, O.2
Forster, M.3
-
34
-
-
84924700879
-
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
-
Psichas A, Sleeth ML, Murphy KG, et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond). 2014.
-
(2014)
Int J Obes (Lond)
-
-
Psichas, A.1
Sleeth, M.L.2
Murphy, K.G.3
-
35
-
-
57349142454
-
Identification and functional characterization of allosteric agonists for the G proteincoupled receptor FFA2
-
Lee T, Schwandner R, Swaminath G, et al. Identification and functional characterization of allosteric agonists for the G proteincoupled receptor FFA2. Mol Pharmacol. 2008; 74(6): 1599-609.
-
(2008)
Mol Pharmacol
, vol.74
, Issue.6
, pp. 1599-1609
-
-
Lee, T.1
Schwandner, R.2
Swaminath, G.3
-
36
-
-
79953216793
-
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: Identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3
-
Schmidt J, Smith NJ, Christiansen E, et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J Biol Chem. 2011; 286(12): 10628-40.
-
(2011)
J Biol Chem
, vol.286
, Issue.12
, pp. 10628-10640
-
-
Schmidt, J.1
Smith, N.J.2
Christiansen, E.3
-
37
-
-
84879037150
-
Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor
-
Hudson BD, Due-Hansen ME, Christiansen E, et al. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. J Biol Chem. 2013; 288(24): 17296-312.
-
(2013)
J Biol Chem
, vol.288
, Issue.24
, pp. 17296-17312
-
-
Hudson, B.D.1
Due-Hansen, M.E.2
Christiansen, E.3
-
38
-
-
85039823393
-
Compounds, pharmaceutical composition and methods for use in treating metabolic disorders. PCT Int. Appl. WO2010066682
-
Hoveyda H, Brantis CE, Dutheuil G, et al. Compounds, pharmaceutical composition and methods for use in treating metabolic disorders. PCT Int. Appl. WO2010066682, June 17; 2010.
-
(2010)
June
, pp. 17
-
-
Hoveyda, H.1
Brantis, C.E.2
Dutheuil, G.3
-
39
-
-
84874375020
-
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
-
WO2011076734, June 30
-
Hoveyda H, Brantis CE, Dutheuil G, et al. Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases. PCT Int. Appl. WO2011076734, June 30; 2011.
-
(2011)
PCT Int. Appl
-
-
Hoveyda, H.1
Brantis, C.E.2
Dutheuil, G.3
-
41
-
-
0742305675
-
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein- coupled receptor GPR41
-
Xiong Y, Miyamoto N, Shibata K, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein- coupled receptor GPR41. Proc Natl Acad Sci U S A. 2004; 101(4): 1045-50.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, Issue.4
, pp. 1045-1050
-
-
Xiong, Y.1
Miyamoto, N.2
Shibata, K.3
-
42
-
-
77951222945
-
Regulation of adipokine production in human adipose tissue by propionic acid
-
Al-Lahham SH, Roelofsen H, Priebe M, et al. Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest. 2010; 40(5): 401-7.
-
(2010)
Eur J Clin Invest
, vol.40
, Issue.5
, pp. 401-407
-
-
Al-Lahham, S.H.1
Roelofsen, H.2
Priebe, M.3
-
43
-
-
77952957384
-
Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids
-
Zaibi MS, Stocker CJ, O'Dowd J, et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 2010; 584(11): 2381-6.
-
(2010)
FEBS Lett
, vol.584
, Issue.11
, pp. 2381-2386
-
-
Zaibi, M.S.1
Stocker, C.J.2
O'dowd, J.3
-
44
-
-
51449119654
-
Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions
-
Tazoe H, Otomo Y, Kaji I, et al. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol. 2008; 59 Suppl 2: 251-62.
-
(2008)
J Physiol Pharmacol
, vol.59
, pp. 251-262
-
-
Tazoe, H.1
Otomo, Y.2
Kaji, I.3
-
45
-
-
70149102106
-
Expression of short-chain fatty acid receptor GPR41 in the human colon
-
Tazoe H, Otomo Y, Karaki S, et al. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009; 30(3): 149-56.
-
(2009)
Biomed Res
, vol.30
, Issue.3
, pp. 149-156
-
-
Tazoe, H.1
Otomo, Y.2
Karaki, S.3
-
46
-
-
84861196704
-
Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation
-
Inoue D, Kimura I, Wakabayashi M, et al. Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Lett. 2012; 586(10): 1547-54.
-
(2012)
FEBS Lett
, vol.586
, Issue.10
, pp. 1547-1554
-
-
Inoue, D.1
Kimura, I.2
Wakabayashi, M.3
-
47
-
-
84862005991
-
GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins
-
Bahar Halpern K, Veprik A, Rubins N, Naaman O, Walker MD. GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins. J Biol Chem. 2012; 287(24): 20154-63.
-
(2012)
J Biol Chem
, vol.287
, Issue.24
, pp. 20154-20163
-
-
Bahar Halpern, K.1
Veprik, A.2
Rubins, N.3
Naaman, O.4
Walker, M.D.5
-
48
-
-
84884693129
-
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes
-
Nohr MK, Pedersen MH, Gille A, et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology. 2013; 154(10): 3552-64.
-
(2013)
Endocrinology
, vol.154
, Issue.10
, pp. 3552-3564
-
-
Nohr, M.K.1
Pedersen, M.H.2
Gille, A.3
-
49
-
-
84892814749
-
Micro-biota-generated metabolites promote metabolic benefits via gut- brain neural circuits
-
De Vadder F, Kovatcheva-Datchary P, Goncalves D, et al. Micro-biota-generated metabolites promote metabolic benefits via gut- brain neural circuits. Cell. 2014; 156(1-2): 84-96.
-
(2014)
Cell
, vol.156
, Issue.1-2
, pp. 84-96
-
-
De Vadder, F.1
Kovatcheva-Datchary, P.2
Goncalves, D.3
-
50
-
-
13444263540
-
Free fatty acids regulategut incretin glucagon-like peptide-1 secretion through GPR120
-
Hirasawa A, Tsumaya K, Awaji T, et al. Free fatty acids regulategut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005; 11(1): 90-4.
-
(2005)
Nat Med
, vol.11
, Issue.1
, pp. 90-94
-
-
Hirasawa, A.1
Tsumaya, K.2
Awaji, T.3
-
51
-
-
84903512937
-
Role of free fatty acid receptors in the regulation of energy metabolism
-
Hara T, Kashihara D, Ichimura A, et al. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim Biophys Acta. 2014; 1841(9): 1292-300.
-
(2014)
Biochim Biophys Acta
, vol.1841
, Issue.9
, pp. 1292-1300
-
-
Hara, T.1
Kashihara, D.2
Ichimura, A.3
-
52
-
-
33745854213
-
Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic beta-cells exposed to palmitate
-
Welters HJ, Diakogiannaki E, Mordue JM, et al. Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic beta-cells exposed to palmitate. Apoptosis. 2006; 11(7): 1231-8.
-
(2006)
Apoptosis
, vol.11
, Issue.7
, pp. 1231-1238
-
-
Welters, H.J.1
Diakogiannaki, E.2
Mordue, J.M.3
-
53
-
-
34547590401
-
Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys
-
Ma D, Tao B, Warashina S, et al. Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys. Neurosci Res. 2007; 58(4): 394-401.
-
(2007)
Neurosci Res
, vol.58
, Issue.4
, pp. 394-401
-
-
Ma, D.1
Tao, B.2
Warashina, S.3
-
54
-
-
52749098923
-
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
-
Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008; 57(9): 2280-7.
-
(2008)
Diabetes
, vol.57
, Issue.9
, pp. 2280-2287
-
-
Edfalk, S.1
Steneberg, P.2
Edlund, H.3
-
55
-
-
53549127020
-
Free fatty acid receptors and drug discovery
-
Hirasawa A, Hara T, Katsuma S, Adachi T, Tsujimoto G. Free fatty acid receptors and drug discovery. Biol Pharm Bull. 2008; 31(10): 1847-51.
-
(2008)
Biol Pharm Bull
, vol.31
, Issue.10
, pp. 1847-1851
-
-
Hirasawa, A.1
Hara, T.2
Katsuma, S.3
Adachi, T.4
Tsujimoto, G.5
-
56
-
-
77954134133
-
Taste preference for fatty acids is mediated by GPR40 and GPR120
-
Cartoni C, Yasumatsu K, Ohkuri T, et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci. 2010; 30(25): 8376-82.
-
(2010)
J Neurosci
, vol.30
, Issue.25
, pp. 8376-8382
-
-
Cartoni, C.1
Yasumatsu, K.2
Ohkuri, T.3
-
57
-
-
79952315396
-
The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin
-
Liou AP, Lu X, Sei Y, et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology. 2011; 140(3): 903-12.
-
(2011)
Gastroenterology
, vol.140
, Issue.3
, pp. 903-912
-
-
Liou, A.P.1
Lu, X.2
Sei, Y.3
-
58
-
-
84864491110
-
Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors
-
Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One. 2012; 7(8): e42373.
-
(2012)
Plos One
, vol.7
, Issue.8
-
-
Sykaras, A.G.1
Demenis, C.2
Case, R.M.3
McLaughlin, J.T.4
Smith, C.P.5
-
59
-
-
30944467752
-
Reduction in voltage-gated K+currents in primary cultured rat pancreatic beta-cells by linoleic acids
-
Feng DD, Luo Z, Roh SG, et al. Reduction in voltage-gated K+currents in primary cultured rat pancreatic beta-cells by linoleic acids. Endocrinology. 2006; 147(2): 674-82.
-
(2006)
Endocrinology
, vol.147
, Issue.2
, pp. 674-682
-
-
Feng, D.D.1
Luo, Z.2
Roh, S.G.3
-
60
-
-
72649087595
-
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids
-
Del Guerra S, Bugliani M, D'Aleo V, et al. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. Nutr Metab Cardiovasc Dis. 2010; 20(1): 22-5.
-
(2010)
Nutr Metab Cardiovasc Dis
, vol.20
, Issue.1
, pp. 22-25
-
-
Del Guerra, S.1
Bugliani, M.2
D'aleo, V.3
-
61
-
-
77957655499
-
Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked in- crease in beta cell mass
-
Fontes G, Zarrouki B, Hagman DK, et al. Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked in- crease in beta cell mass. Diabetologia. 2010; 53(11): 2369-79.
-
(2010)
Diabetologia
, vol.53
, Issue.11
, pp. 2369-2379
-
-
Fontes, G.1
Zarrouki, B.2
Hagman, D.K.3
-
62
-
-
29144463108
-
GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion
-
Itoh Y, Hinuma S. GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion. Hepatol Res. 2005; 33(2): 171-3.
-
(2005)
Hepatol Res
, vol.33
, Issue.2
, pp. 171-173
-
-
Itoh, Y.1
Hinuma, S.2
-
63
-
-
33745607930
-
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: Identification of agonist and antagonist small molecules
-
Briscoe CP, Peat AJ, McKeown SC, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol. 2006; 148(5): 619-28.
-
(2006)
Br J Pharmacol
, vol.148
, Issue.5
, pp. 619-628
-
-
Briscoe, C.P.1
Peat, A.J.2
McKeown, S.C.3
-
64
-
-
34047177401
-
GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo
-
Latour MG, Alquier T, Oseid E, et al. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes. 2007; 56(4): 1087-94.
-
(2007)
Diabetes
, vol.56
, Issue.4
, pp. 1087-1094
-
-
Latour, M.G.1
Alquier, T.2
Oseid, E.3
-
65
-
-
27944449329
-
Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion
-
Salehi A, Flodgren E, Nilsson NE, et al. Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res. 2005; 322(2): 207-15.
-
(2005)
Cell Tissue Res
, vol.322
, Issue.2
, pp. 207-215
-
-
Salehi, A.1
Flodgren, E.2
Nilsson, N.E.3
-
66
-
-
33751520308
-
Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40
-
Schnell S, Schaefer M, Schofl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol Cell Endocrinol. 2007; 263(12): 173-80.
-
(2007)
Mol Cell Endocrinol
, vol.263
, Issue.12
, pp. 173-180
-
-
Schnell, S.1
Schaefer, M.2
Schofl, C.3
-
67
-
-
20944433543
-
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse
-
Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 2005; 1(4): 245-58.
-
(2005)
Cell Metab
, vol.1
, Issue.4
, pp. 245-258
-
-
Steneberg, P.1
Rubins, N.2
Bartoov-Shifman, R.3
Walker, M.D.4
Edlund, H.5
-
68
-
-
65549114432
-
Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice
-
Nagasumi K, Esaki R, Iwachidow K, et al. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes. 2009; 58(5): 1067-76.
-
(2009)
Diabetes
, vol.58
, Issue.5
, pp. 1067-1076
-
-
Nagasumi, K.1
Esaki, R.2
Iwachidow, K.3
-
69
-
-
84882761792
-
GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats
-
Meidute Abaraviciene S, Muhammed SJ, Amisten S, Lundquist I, Salehi A. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats. Mol Cell Endocrinol. 2013; 381(1-2): 150-9.
-
(2013)
Mol Cell Endocrinol
, vol.381
, Issue.1-2
, pp. 150-159
-
-
Meidute Abaraviciene, S.1
Muhammed, S.J.2
Amisten, S.3
Lundquist, I.4
Salehi, A.5
-
70
-
-
52749098923
-
Gpr40 is expressed in enteroen-docrine cells and mediates FFA stimulation of incretin secretion
-
Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroen-docrine cells and mediates FFA stimulation of incretin secretion. Diabetes. 2008.
-
(2008)
Diabetes
-
-
Edfalk, S.1
Steneberg, P.2
Edlund, H.3
-
71
-
-
80053138180
-
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats
-
Tsujihata Y, Ito R, Suzuki M, et al. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. J Pharmacol Exp Ther. 2011; 339(1): 228-37.
-
(2011)
J Pharmacol Exp Ther
, vol.339
, Issue.1
, pp. 228-237
-
-
Tsujihata, Y.1
Ito, R.2
Suzuki, M.3
-
72
-
-
84857032603
-
GPR40-induced insulin secretion by the novel agonist TAK-875: First clinical findings in patients with type 2 diabetes
-
Araki T, Hirayama M, Hiroi S, Kaku K. GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab. 2012; 14(3): 271-8.
-
(2012)
Diabetes Obes Metab
, vol.14
, Issue.3
, pp. 271-278
-
-
Araki, T.1
Hirayama, M.2
Hiroi, S.3
Kaku, K.4
-
73
-
-
84859563640
-
Could FFAR1 assist insulin secretion in type 2 diabetes?
-
Bailey CJ. Could FFAR1 assist insulin secretion in type 2 diabetes? Lancet. 2012; 379(9824): 1370-1.
-
(2012)
Lancet
, vol.379
, Issue.9824
, pp. 1370-1371
-
-
Bailey, C.J.1
-
74
-
-
84859625938
-
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: A phase 2, randomised, double-blind, placebo-controlled trial
-
Burant CF, Viswanathan P, Marcinak J, et al. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2012; 379(9824): 1403-11.
-
(2012)
Lancet
, vol.379
, Issue.9824
, pp. 1403-1411
-
-
Burant, C.F.1
Viswanathan, P.2
Marcinak, J.3
-
75
-
-
84862589520
-
A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes
-
Leifke E, Naik H, Wu J, et al. A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes. Clin Pharmacol Ther. 2012; 92(1): 29-39.
-
(2012)
Clin Pharmacol Ther
, vol.92
, Issue.1
, pp. 29-39
-
-
Leifke, E.1
Naik, H.2
Wu, J.3
-
76
-
-
84863208301
-
Safety, tolerability, pharma-cokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: Results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers
-
Naik H, Vakilynejad M, Wu J, et al. Safety, tolerability, pharma-cokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers. J Clin Pharmacol. 2012; 52(7): 1007-16.
-
(2012)
J Clin Pharmacol
, vol.52
, Issue.7
, pp. 1007-1016
-
-
Naik, H.1
Vakilynejad, M.2
Wu, J.3
-
77
-
-
84880964021
-
The fatty acid receptor FFA1/GPR40 a decade later: How much do we know?
-
Mancini AD, Poitout V. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Trends Endocrinol Metab. 2013; 24(8): 398-407.
-
(2013)
Trends Endocrinol Metab
, vol.24
, Issue.8
, pp. 398-407
-
-
Mancini, A.D.1
Poitout, V.2
-
78
-
-
84889083042
-
Modulating GPR40: Therapeutic promise and potential in diabetes
-
Poitout V, Lin DC. Modulating GPR40: therapeutic promise and potential in diabetes. Drug Discov Today. 2013; 18(23-24): 1301-8
-
(2013)
Drug Discov Today
, vol.18
, Issue.23-24
, pp. 1301-1308
-
-
Poitout, V.1
Lin, D.C.2
-
79
-
-
84885417075
-
A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1
-
Yabuki C, Komatsu H, Tsujihata Y, et al. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1. PLoS One. 2013; 8(10): e76280.
-
(2013)
Plos One
, vol.8
, Issue.10
-
-
Yabuki, C.1
Komatsu, H.2
Tsujihata, Y.3
-
80
-
-
84866357145
-
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
-
Brown SP, Dransfield PJ, Vimolratana M, et al. Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. ACS Med Chem Lett. 2012; 3(9): 726-30.
-
(2012)
ACS Med Chem Lett
, vol.3
, Issue.9
, pp. 726-730
-
-
Brown, S.P.1
Dransfield, P.J.2
Vimolratana, M.3
-
81
-
-
84879092042
-
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
-
Wang Y, Liu JJ, Dransfield PJ, et al. Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles. ACS Med Chem Lett. 2013; 4(6): 551-5.
-
(2013)
ACS Med Chem Lett
, vol.4
, Issue.6
, pp. 551-555
-
-
Wang, Y.1
Liu, J.J.2
Dransfield, P.J.3
-
82
-
-
84902546389
-
Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus
-
Defossa E, Wagner M. Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus. Bioorg Med Chem Lett. 2014; 24(14): 2991-3000.
-
(2014)
Bioorg Med Chem Lett
, vol.24
, Issue.14
, pp. 2991-3000
-
-
Defossa, E.1
Wagner, M.2
-
83
-
-
84901786045
-
Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists
-
Takano R, Yoshida M, Inoue M, et al. Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists. Bioorg Med Chem Lett. 2014; 24(13): 2949-53.
-
(2014)
Bioorg Med Chem Lett
, vol.24
, Issue.13
, pp. 2949-2953
-
-
Takano, R.1
Yoshida, M.2
Inoue, M.3
-
84
-
-
80053910894
-
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties
-
Christiansen E, Urban C, Grundmann M, et al. Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. J Med Chem. 2011; 54(19): 6691-703.
-
(2011)
J Med Chem
, vol.54
, Issue.19
, pp. 6691-6703
-
-
Christiansen, E.1
Urban, C.2
Grundmann, M.3
-
85
-
-
84873900885
-
Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability
-
Christiansen E, Due-Hansen ME, Urban C, et al. Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. J Med Chem. 2013; 56(3): 982-92.
-
(2013)
J Med Chem
, vol.56
, Issue.3
, pp. 982-992
-
-
Christiansen, E.1
Due-Hansen, M.E.2
Urban, C.3
-
86
-
-
84877710397
-
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
-
Christiansen E, Hansen SV, Urban C, et al. Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes. ACS Med Chem Lett. 2013; 4(5): 441-5.
-
(2013)
ACS Med Chem Lett
, vol.4
, Issue.5
, pp. 441-445
-
-
Christiansen, E.1
Hansen, S.V.2
Urban, C.3
-
87
-
-
33751311273
-
Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach
-
Fukunaga S, Setoguchi S, Hirasawa A, Tsujimoto G. Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach. Life Sci. 2006; 80(1): 17-23.
-
(2006)
Life Sci
, vol.80
, Issue.1
, pp. 17-23
-
-
Fukunaga, S.1
Setoguchi, S.2
Hirasawa, A.3
Tsujimoto, G.4
-
88
-
-
68349086914
-
Novel selective ligands for free fatty acid receptors GPR120 and GPR40
-
Hara T, Hirasawa A, Sun Q, et al. Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiedebergs Arch Pharmacol. 2009; 380(3): 247-55.
-
(2009)
Naunyn Schmiedebergs Arch Pharmacol
, vol.380
, Issue.3
, pp. 247-255
-
-
Hara, T.1
Hirasawa, A.2
Sun, Q.3
-
89
-
-
21244503501
-
Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1
-
Katsuma S, Hatae N, Yano T, et al. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J Biol Chem. 2005; 280(20): 19507-15.
-
(2005)
J Biol Chem
, vol.280
, Issue.20
, pp. 19507-19515
-
-
Katsuma, S.1
Hatae, N.2
Yano, T.3
-
90
-
-
58149464981
-
Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
-
Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia. 2009; 52(2): 289-98.
-
(2009)
Diabetologia
, vol.52
, Issue.2
, pp. 289-298
-
-
Parker, H.E.1
Habib, A.M.2
Rogers, G.J.3
Gribble, F.M.4
Reimann, F.5
-
91
-
-
0034306187
-
Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag
-
Sidhu SS, Thompson DG, Warhurst G, Case RM, Benson RS. Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J Physiol. 2000; 528 Pt 1: 165-76.
-
J Physiol. 2000; 528 Pt
, vol.1
, pp. 165-176
-
-
Sidhu, S.S.1
Thompson, D.G.2
Warhurst, G.3
Case, R.M.4
Benson, R.S.5
-
92
-
-
84916898719
-
Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects
-
Yore MM, Syed I, Moraes-Vieira PM, et al. Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects. Cell. 2014; 159(2): 318-32.
-
(2014)
Cell
, vol.159
, Issue.2
, pp. 318-332
-
-
Yore, M.M.1
Syed, I.2
Moraes-Vieira, P.M.3
-
93
-
-
33846468320
-
The regulation of adipogenesis through GPR120
-
Gotoh C, Hong YH, Iga T, et al. The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun. 2007; 354(2): 591-7.
-
(2007)
Biochem Biophys Res Commun
, vol.354
, Issue.2
, pp. 591-597
-
-
Gotoh, C.1
Hong, Y.H.2
Iga, T.3
-
94
-
-
84888637223
-
Phenotypic characterization of GPR120-expressing cells in the interstitial tissue of pancreas
-
Zhao Y, Zha D, Wang L, et al. Phenotypic characterization of GPR120-expressing cells in the interstitial tissue of pancreas. Tissue Cell. 2013; 45(6): 421-7.
-
(2013)
Tissue Cell
, vol.45
, Issue.6
, pp. 421-427
-
-
Zhao, Y.1
Zha, D.2
Wang, L.3
-
95
-
-
84901191678
-
GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans
-
Stone VM, Dhayal S, Brocklehurst KJ, et al. GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia. 2014; 57(6): 1182-91.
-
(2014)
Diabetologia
, vol.57
, Issue.6
, pp. 1182-1191
-
-
Stone, V.M.1
Dhayal, S.2
Brocklehurst, K.J.3
-
96
-
-
58149334788
-
Colocalization of GPR120 with phospholipase-Cbeta2 and alpha-gustducin in the taste bud cells in mice
-
Matsumura S, Eguchi A, Mizushige T, et al. Colocalization of GPR120 with phospholipase-Cbeta2 and alpha-gustducin in the taste bud cells in mice. Neurosci Lett. 2009; 450(2): 186-90.
-
(2009)
Neurosci Lett
, vol.450
, Issue.2
, pp. 186-190
-
-
Matsumura, S.1
Eguchi, A.2
Mizushige, T.3
-
97
-
-
84867347584
-
Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: Putative involvement of GPR120 and impact on taste sensitivity
-
Martin C, Passilly-Degrace P, Chevrot M, et al. Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res. 2012; 53(11): 2256-65.
-
(2012)
J Lipid Res
, vol.53
, Issue.11
, pp. 2256-2265
-
-
Martin, C.1
Passilly-Degrace, P.2
Chevrot, M.3
-
98
-
-
84896491736
-
CD36- and GPR120-mediated Ca(2)(+) signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice
-
Ozdener MH, Subramaniam S, Sundaresan S, et al. CD36- and GPR120-mediated Ca(2)(+) signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice. Gastroenterology. 2014; 146(4): 995-1005.
-
(2014)
Gastroenterology
, vol.146
, Issue.4
, pp. 995-1005
-
-
Ozdener, M.H.1
Subramaniam, S.2
Sundaresan, S.3
-
99
-
-
84863516095
-
A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets
-
Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012; 16(1): 122-34.
-
(2012)
Cell Metab
, vol.16
, Issue.1
, pp. 122-134
-
-
Taneera, J.1
Lang, S.2
Sharma, A.3
-
100
-
-
84895825811
-
Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion
-
Paulsen SJ, Larsen LK, Hansen G, et al. Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion. PLoS One. 2014; 9(2): e88227.
-
(2014)
Plos One
, vol.9
, Issue.2
-
-
Paulsen, S.J.1
Larsen, L.K.2
Hansen, G.3
-
101
-
-
84886060164
-
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism
-
Hudson BD, Shimpukade B, Mackenzie AE, et al. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol. 2013; 84(5): 710-25.
-
(2013)
Mol Pharmacol
, vol.84
, Issue.5
, pp. 710-725
-
-
Hudson, B.D.1
Shimpukade, B.2
Mackenzie, A.E.3
-
102
-
-
84890063785
-
The therapeutic potential of GPR120: A patent review
-
Halder S, Kumar S, Sharma R. The therapeutic potential of GPR120: a patent review. Expert Opin Ther Pat. 2013; 23(12): 1581-90.
-
(2013)
Expert Opin Ther Pat
, vol.23
, Issue.12
, pp. 1581-1590
-
-
Halder, S.1
Kumar, S.2
Sharma, R.3
-
105
-
-
77956500937
-
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist
-
Negoro N, Sasaki S, Mikami S, et al. Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist. ACS Med Chem Lett. 2010; 1(6): 290-4.
-
(2010)
ACS Med Chem Lett
, vol.1
, Issue.6
, pp. 290-294
-
-
Negoro, N.1
Sasaki, S.2
Mikami, S.3
-
106
-
-
84892563863
-
Novel compounds, method for usethem and pharmaceutical composition containing them
-
WO2011151436, December 8
-
Hoveyda H, Zoute L, Lenoir F. Novel compounds, method for usethem and pharmaceutical composition containing them. PCT Int. Appl. WO2011151436, December 8; 2011.
-
(2011)
PCT Int. Appl
-
-
Hoveyda, H.1
Zoute, L.2
Lenoir, F.3
-
107
-
-
84952707848
-
Gpr41 and modulatorsthereof for the treatment of insulin-related disorders
-
WO2006052566, May 18
-
Douglas BP, A BM, Liang CZ, N LJ. Gpr41 and modulatorsthereof for the treatment of insulin-related disorders. PCT Int. Appl. WO2006052566, May 18; 2006.
-
(2006)
PCT Int. Appl
-
-
Douglas, B.P.1
Bm, A.2
Liang, C.Z.3
Lj, N.4
-
108
-
-
77958142515
-
Structure-activity relationshipsof GPR120 agonists based on a docking simulation
-
Sun Q, Hirasawa A, Hara T, et al. Structure-activity relationshipsof GPR120 agonists based on a docking simulation. Mol Pharmacol. 2010; 78(5): 804-10.
-
(2010)
Mol Pharmacol
, vol.78
, Issue.5
, pp. 804-810
-
-
Sun, Q.1
Hirasawa, A.2
Hara, T.3
-
109
-
-
84907612482
-
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
-
Oh da Y, Walenta E, Akiyama TE, et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med. 2014; 20(8): 942-7.
-
(2014)
Nat Med
, vol.20
, Issue.8
, pp. 942-947
-
-
Oh Da, Y.1
Walenta, E.2
Akiyama, T.E.3
|